MMP9 and breast carcinoma: The validation of target genes by using ONCOMINE showed that, in samples from a TCGA study, the mRNA level of MMP9 was significantly higher in metastatic breast cancer cells than in normal breast cells with p=2.97 × 10−16 (Figure 6).